𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Erythroleukemic phase of mouse myeloproliferative syndrome

✍ Scribed by S. Albert; Paul L. Wolf; I. Pryjma; J. Vazquez

Publisher
John Wiley and Sons
Year
1967
Tongue
English
Weight
796 KB
Volume
20
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of chloride transport in mous
Comparison of chloride transport in mouse erythrocytes and friend virus-transformed erythroleukemic cells
✍ Patricia A. Harper; Philip A. Knauf 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 803 KB

## Abstract Friend erythroleukemic cells, which grow continuously in tissue culture, resemble in many respects early precursors of mouse erythrocytes. To determine whether or not the membranes of these cells exhibit the rapid and selective exchange of chloride, a specialized feature of the mature e

Identification of a novel gene, FGFR1OP2
Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome
✍ Effie K. Grand; Francis H. Grand; Andrew J. Chase; Fiona M. Ross; Martin M Corco 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 429 KB

## Abstract The 8p11 myeloproliferative syndrome (EMS) is an aggressive hematological malignancy caused by the fusion of diverse partner genes to fibroblast growth factor receptor 1 (__FGFR1__). The partner proteins promote dimerization and ligand‐independent activation of __FGFR1__‐encoded tyrosin

CXCR4-independent rescue of the myelopro
CXCR4-independent rescue of the myeloproliferative defect of the gata1low myelofibrosis mouse model by Aplidin®
✍ Maria Verrucci; Alessandro Pancrazzi; Miguel Aracil; Fabrizio Martelli; Paola Gu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 776 KB

## Abstract The discovery of JAK2 mutations in Philadelphia‐negative myeloproliferative neoplasms has prompted investigators to evaluate mutation‐targeted treatments to restore hematopoietic cell functions in these diseases. However, the results of the first clinical trials with JAK2 inhibitors are

Differentiation-inducing and growth-inhi
Differentiation-inducing and growth-inhibitory activities of erythroid differentiation factor (EDF/activin A) toward mouse erythroleukemic cells in vivo
✍ Makoto Shiozaki; Shigeru Shioya; Masaaki Izawa; Yuzuru Eto; Hiroshiro Shibai 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 595 KB

The in vivo differentiation-inducing activity of a purified human erythroid differentiation factor (EDF) toward mouse erythroleukemic cells (MEL cells) was examined. BDF, mice with diffusion chambers implanted in the peritoneal cavity were treated with continuous i.p. administration of EDF. MEL cell

A transgenic mouse model of the slow-cha
A transgenic mouse model of the slow-channel syndrome
✍ Christopher M. Gomez; Bula B. Bhattacharyya; Pierre Charnet; John W. Day; Cesar 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 861 KB

To investigate the effect of acetylcholine receptor (AChR) mutations on neuromuscular transmission and to develop a model for the human neuromuscular disease, the slow-channel syndrome, we generated transgenic mice with abnormal AChRs using a 6 subunit with a mutation in the ion channel domain. In t